Skip to main content

Table 1 Demographic and clinical data of the study population

From: Amelioration of polycystic ovary syndrome-related disorders by supplementation of thymoquinone and metformin

 

Group A

N = 104

Group B

N = 103

P

Age

24.59 ± 5.3

24.48 ± 4.9

0.88

Marital status

 Married

73 (70.2%)

71 (68.9%)

0.8

 Single

31 (29.8%)

32 (31.1%)

4

Oligomenorrhea or amenorrhea

104 (100%)

103 (100%)

1.0

BMI (kg/m2)

29.65 ± 4.39

29.71 ± 4.13

0.94

Waist circumference (cm)

98.5 ± 10

98.3 ± 9

0.87

Hip circumference (cm)

120.4 ± 11

120.2 ± 10

0.89

Waist:hip ratio

0.86 ± 0.05

0.85 ± 0.04

0.67

Number of prediabetes cases

35 (33.6%)

34 (33.0%)

0.95

Serum SOD activity (U/mg protein)

44.36 ± 14.26

44.25 ± 19.37

0.96

MDA concentrations (μmol/l)

0.31 ± 0.03

0.32 ± 0.04

0.47